These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32795340)

  • 1. Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma.
    Shiba S; Shibuya K; Okamoto M; Okazaki S; Komatsu S; Kubota Y; Nakano T; Ohno T
    Radiat Oncol; 2020 Aug; 15(1):195. PubMed ID: 32795340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger.
    Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
    Radiother Oncol; 2019 Mar; 132():230-235. PubMed ID: 30366726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.
    Shiba S; Abe T; Shibuya K; Katoh H; Koyama Y; Shimada H; Kakizaki S; Shirabe K; Kuwano H; Ohno T; Nakano T
    BMC Cancer; 2017 Nov; 17(1):721. PubMed ID: 29115938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Dose Distributions When Using Carbon Ion Radiotherapy Versus Intensity-modulated Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Retrospective Analysis.
    Shiba S; Shibuya K; Kawashima M; Okano N; Kaminuma T; Okamoto M; Kubota Y; Nakano T; Ohno T
    Anticancer Res; 2020 Jan; 40(1):459-464. PubMed ID: 31892601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma.
    Bae SH; Park HC; Lim DH; Lee JA; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e603-7. PubMed ID: 22208963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
    Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
    BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
    Kasuya G; Kato H; Yasuda S; Tsuji H; Yamada S; Haruyama Y; Kobashi G; Ebner DK; Okada NN; Makishima H; Miyazaki M; Kamada T; Tsujii H;
    Cancer; 2017 Oct; 123(20):3955-3965. PubMed ID: 28662297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study.
    Kaneko T; Makishima H; Wakatsuki M; Hiroshima Y; Matsui T; Yasuda S; Okada NN; Nemoto K; Tsuji H; Yamada S; Miyazaki M
    BMC Cancer; 2024 Mar; 24(1):383. PubMed ID: 38532338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.
    Habermehl D; Debus J; Ganten T; Ganten MK; Bauer J; Brecht IC; Brons S; Haberer T; Haertig M; Jäkel O; Parodi K; Welzel T; Combs SE
    Radiat Oncol; 2013 Mar; 8():59. PubMed ID: 23497349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study.
    Shibuya K; Ohno T; Terashima K; Toyama S; Yasuda S; Tsuji H; Okimoto T; Shioyama Y; Nemoto K; Kamada T; Nakano T;
    Liver Int; 2018 Dec; 38(12):2239-2247. PubMed ID: 30240527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT.
    Hou JZ; Zeng ZC; Wang BL; Yang P; Zhang JY; Mo HF
    Jpn J Clin Oncol; 2016 Apr; 46(4):357-62. PubMed ID: 26802166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
    Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
    Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?
    Yu JI; Park HC; Lim DH; Paik SW
    Cancer Res Treat; 2016 Apr; 48(2):574-82. PubMed ID: 26194367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
    Kawashiro S; Yamada S; Okamoto M; Ohno T; Nakano T; Shinoto M; Shioyama Y; Nemoto K; Isozaki Y; Tsuji H; Kamada T
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1212-1221. PubMed ID: 29907490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-ion Radiotherapy for Oligometastatic Colorectal Cancer in the Liver or Lung.
    Shiba S; Shibuya K; Okamoto M; Okano N; Kubo N; Kaminuma T; Sato H; Okazaki S; Miyasaka Y; Kawamura H; Ohno T
    Anticancer Res; 2021 Apr; 41(4):1997-2005. PubMed ID: 33813406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma.
    Byun HK; Kim HJ; Im YR; Kim DY; Han KH; Seong J
    Radiother Oncol; 2019 Apr; 133():1-8. PubMed ID: 30935563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.
    Combs SE; Habermehl D; Ganten T; Schmidt J; Edler L; Burkholder I; Jäkel O; Haberer T; Debus J
    BMC Cancer; 2011 Feb; 11():67. PubMed ID: 21314962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma.
    Park S; Yoon WS; Jang MH; Rim CH
    Int J Radiat Biol; 2020 Dec; 96(12):1541-1549. PubMed ID: 32990486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of Re-irradiation with Carbon-ion Radiotherapy for Lymph Node Recurrence of Gynecological Cancers.
    Shiba S; Okonogi N; Kato S; Wakatsuki M; Kobayashi D; Kiyohara H; Ohno T; Karasawa K; Nakano T; Kamada T
    Anticancer Res; 2017 Oct; 37(10):5577-5583. PubMed ID: 28982873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.